These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10727138)

  • 1. The potential replacement of HPLC by 125I-RIA for the characterization of cyclosporin A: a bioavailability study after oral administration in healthy human subjects.
    Lee YJ; Chung SJ; Shim CK
    J Pharm Biomed Anal; 2000 Feb; 22(1):183-8. PubMed ID: 10727138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant discrepancy in cyclosporin A post-dose concentrations when analyzed with specific RIA and HPLC method.
    Grundmann M; Perinova I; Brozmanova H; Koristkova B; Safarcik K
    Int J Clin Pharmacol Ther; 2010 Feb; 48(2):87-92. PubMed ID: 20137760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The possibility of using the specific RIA method for the area-under-time-concentration curve sparse sampling calculation of cyclosporin A despite a large post-dose overestimation.
    Grundmann M; Koristkova B; Brozmanova H; Perinova I; Safarcik K
    Int J Clin Pharmacol Ther; 2011 Jan; 49(1):30-7. PubMed ID: 21176722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine metabolism and pharmacokinetics following intravenous and oral administration in the dog.
    Gridelli B; Scanlon L; Pellicci R; LaPointe R; DeWolf A; Seltman H; Diven W; Shaw B; Starzl T; Sanghvi A
    Transplantation; 1986 Mar; 41(3):388-91. PubMed ID: 3952805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased oral availability of cyclosporin A at second administration in humans.
    Lee YJ; Chung SJ; Shim CK
    Br J Clin Pharmacol; 1997 Oct; 44(4):343-5. PubMed ID: 9354308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of cyclosporine in plasma from patients with various transplants: HPLC radioimmunoassay with a specific monoclonal antibody compared.
    McBride JH; Rodgerson DO; Park SS; Reyes AF
    Clin Chem; 1989 Aug; 35(8):1726-30. PubMed ID: 2667807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable bioavailability of cyclosporin A, regardless of food intake, from soft gelatin capsules containing a new self-nanoemulsifying formulation.
    Yang SG; Kim DD; Chung SJ; Shim CK
    Int J Clin Pharmacol Ther; 2006 May; 44(5):233-9. PubMed ID: 16724578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine bioequivalence study: quantification using fluorescence polarization immunoassay (FPIA) and radioimmunoassay (RIA).
    Mendes GD; de Oliveira CH; Sucupira M; Donato JL; Moreno RA; De Nucci G
    Int J Clin Pharmacol Ther; 2004 Feb; 42(2):125-32. PubMed ID: 15180174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.
    Schädeli F; Marti HP; Frey FJ; Uehlinger DE
    Clin Pharmacokinet; 2002; 41(1):59-69. PubMed ID: 11825097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vivo bioequivalence and in vitro dissolution of two cyclosporin A soft gelatin capsule formulations.
    Avramoff A; Laor A; Kitzes-Cohen R; Farin D; Domb AJ
    Int J Clin Pharmacol Ther; 2007 Feb; 45(2):126-32. PubMed ID: 17323793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of cyclosporine concentrations in whole blood: HPLC and radioimmunoassay with a specific monoclonal antibody and 3H- or 125I-labeled ligand compared.
    Wolf BA; Daft MC; Koenig JW; Flye MW; Turk JW; Scott MG
    Clin Chem; 1989 Jan; 35(1):120-4. PubMed ID: 2642760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cicloral versus neoral: a bioequivalence study in healthy volunteers on the influence of a fat-rich meal on the bioavailability of cicloral.
    Kees F; Mair G; Dittmar M; Bucher M
    Transplant Proc; 2004 Dec; 36(10):3234-8. PubMed ID: 15686736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of assay methodology on pharmacokinetic differences between cyclosporine Neoral and Sandimmune formulations.
    Aspeslet LJ; LeGatt DF; Murphy G; Yatscoff RW
    Clin Chem; 1997 Jan; 43(1):104-8. PubMed ID: 8990230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic monitoring of cyclosporine: impact of a change in standards on 125I-monoclonal RIA performance in comparison with liquid chromatography.
    Keown PA; Glenn J; Denegri J; Maciejewska U; Seccombe D; Stawecki M; Freeman D; Stiller C; Shackleton C; Cameron E
    Clin Chem; 1990 May; 36(5):804-7. PubMed ID: 2337993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bioequivalence research of cyclosporin soft capsules].
    Wu Y; Mao M; Wang L; Jiang X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Apr; 29(2):311-4, 331. PubMed ID: 22616181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific enzyme-multiplied immunoassay and fluorescence polarization immunoassay for cyclosporin compared with Cyclotrac [125I]radioimmunoassay.
    Morris RG; Saccoia NC; Ryall RG; Peacock MK; Sallustio BC
    Ther Drug Monit; 1992 Jun; 14(3):226-33. PubMed ID: 1412609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of factors to decrease bioavailability of cyclosporin A in rats with gentamicin-induced acute renal failure.
    Shibata N; Inoue Y; Fukumoto K; Nishimura A; Fukushima K; Yoshikawa Y; Spiteller G; Takada K
    Biol Pharm Bull; 2004 Mar; 27(3):384-91. PubMed ID: 14993807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A.
    Song KH; Fasano A; Eddington ND
    Int J Pharm; 2008 Mar; 351(1-2):8-14. PubMed ID: 17954018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine kinetics in renal transplant patients as assessed by high-performance liquid chromatography and radioimmunoassay using monoclonal and polyclonal antibodies.
    Speck RF; Frey FJ; Frey BM
    Transplantation; 1989 May; 47(5):802-6. PubMed ID: 2655217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.